Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Experimental Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000294102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
by: Zhaleiko, I.O., et al.
Published: (2014)
by: Zhaleiko, I.O., et al.
Published: (2014)
Tyrosine kinase inhibitors in treatment of fibrous histiocytoma
by: Maur, D., et al.
Published: (2009)
by: Maur, D., et al.
Published: (2009)
Influence of tyrosine proteine kinases inhibitor, genestein, on Agrobacterium – mediated plant transformation
by: V. Fedorchuk, et al.
Published: (2015)
by: V. Fedorchuk, et al.
Published: (2015)
Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
by: Ya. A. Sheremet, et al.
Published: (2012)
by: Ya. A. Sheremet, et al.
Published: (2012)
Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
by: Sheremet, Ya.A., et al.
Published: (2012)
by: Sheremet, Ya.A., et al.
Published: (2012)
Inhibitors of tyrosine kinases and phosphatases as a tool for the investigation of microtubule role in plant cold response
by: Ya. A. Sheremet, et al.
Published: (2012)
by: Ya. A. Sheremet, et al.
Published: (2012)
Rational design of protein kinase inhibitors
by: Yarmoluk, S.M., et al.
Published: (2013)
by: Yarmoluk, S.M., et al.
Published: (2013)
Rational design of protein kinase inhibitors
by: S. M. Yarmoluk, et al.
Published: (2013)
by: S. M. Yarmoluk, et al.
Published: (2013)
Janus kinase inhibitors in dermatology: present and future
by: I. M. Serbina, et al.
Published: (2021)
by: I. M. Serbina, et al.
Published: (2021)
Quinazoline inhibitors of protein kinase FGFR1
by: A. A. Hryshchenko, et al.
Published: (2010)
by: A. A. Hryshchenko, et al.
Published: (2010)
Assessment of high-dosed chemotherapy efficiency with following transplantation of autologous hemopoietic cells in patients with multiple myeloma
by: T. P. Zagoskina, et al.
Published: (2008)
by: T. P. Zagoskina, et al.
Published: (2008)
Accompanying immunotherapy using cord blood cryopreserved hemopoietic cells to treat patients with subacute salpingo-oophoritis
by: V. I. Grishchenko, et al.
Published: (2004)
by: V. I. Grishchenko, et al.
Published: (2004)
Pathophysiological mechanisms of epileptic syndrome development under conditions of tyrosine-kinase activity modulation
by: M. P. Pervak
Published: (2017)
by: M. P. Pervak
Published: (2017)
The determination of the relapse risk of chronic myeloid leukemia using the indicators of the functional activity of bone marrow and sokal index
by: D. I. Bilko, et al.
Published: (2014)
by: D. I. Bilko, et al.
Published: (2014)
Using of C60 fullerene complexes with antitumor drugs in chemotherapy
by: S. V. Prylutska
Published: (2014)
by: S. V. Prylutska
Published: (2014)
Calix[4]arene a-hydroxymethylphosphonic acids as potential inhibitors of protein tyrosine phosphatases
by: V. V. Trush, et al.
Published: (2014)
by: V. V. Trush, et al.
Published: (2014)
The influence of protein tyrosine phosphatase inhibitor, sodium ortovanadate, on Agrobacterium-mediated transformation of plants
by: V. V. Fedorchuk, et al.
Published: (2015)
by: V. V. Fedorchuk, et al.
Published: (2015)
The assessment of sulfonylcalix I4I arene derivatives as inhibitors of protein tyrosine phosphatases
by: V. M. Buldenko, et al.
Published: (2018)
by: V. M. Buldenko, et al.
Published: (2018)
Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy
by: Perekhrestenko, T., et al.
Published: (2023)
by: Perekhrestenko, T., et al.
Published: (2023)
Electrical stimulations of cerebellar cortex induce more pronounced antiseizure effects after tyrosin-kinase activity inhibition
by: M. P. Pervak
Published: (2018)
by: M. P. Pervak
Published: (2018)
Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
by: Langabeer, S.E., et al.
Published: (2023)
by: Langabeer, S.E., et al.
Published: (2023)
Hematological effects of the protein kinases inhibitor maleimide derivative of dimethylhydrazineinduced colorectal carcinogenesis of rats
by: I. V. Bielinska, et al.
Published: (2014)
by: I. V. Bielinska, et al.
Published: (2014)
Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)
by: M. V. Sadchykova, et al.
Published: (2020)
by: M. V. Sadchykova, et al.
Published: (2020)
Testing of a new docking scoring function on the example of inhibitors of protein tyrosine phosphatase 1B
by: Yu. Tanchuk, et al.
Published: (2015)
by: Yu. Tanchuk, et al.
Published: (2015)
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy
by: Skrypnyk, I., et al.
Published: (2023)
by: Skrypnyk, I., et al.
Published: (2023)
Evaluation of 4H-4-chromenone derivatives as inhibitors of protein kinase CK2
by: Prykhodko, A.O., et al.
Published: (2005)
by: Prykhodko, A.O., et al.
Published: (2005)
Synthesis and evaluation of new thiazole-containing rhodanine-3-alkanoic acids as inhibitors of protein tyrosine phosphatases and glutathione S-transferases
by: O. L. Kobzar, et al.
Published: (2020)
by: O. L. Kobzar, et al.
Published: (2020)
Search of protein kinase CK2 inhibitors based on purine-2,6-diones derivatives
by: M. V. Protopopov, et al.
Published: (2017)
by: M. V. Protopopov, et al.
Published: (2017)
An inhibitor of Ca2+-dependent protein kinases, trifluoperazine, increases the efficiency of agrobacterium-mediated transformation of tobacco
by: V. V. Fedorchuk, et al.
Published: (2014)
by: V. V. Fedorchuk, et al.
Published: (2014)
Circulating hematopoietic progenitor cells in patients affected by chornobyl accident
by: Bilko, N.M., et al.
Published: (2016)
by: Bilko, N.M., et al.
Published: (2016)
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)
by: L. K. Sokolova, et al.
Published: (2017)
Effect of a Rho Kinase Inhibitor on Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
by: Q. Zhang, et al.
Published: (2015)
by: Q. Zhang, et al.
Published: (2015)
Effect of a Rho Kinase Inhibitor on Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
by: Zhang, Q., et al.
Published: (2015)
by: Zhang, Q., et al.
Published: (2015)
Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco BY-2 cells
by: Ja. A. Sheremet, et al.
Published: (2012)
by: Ja. A. Sheremet, et al.
Published: (2012)
Assessment of hemopoietic potential of bone marrow hemopoietic stem cells with changed initial status under effect of cryopreservation factors
by: A. N. Goltsev, et al.
Published: (2005)
by: A. N. Goltsev, et al.
Published: (2005)
Hemopoietic stem cells for transplantation in patients with oncohematological pathology
by: Zh. A. Misharina, et al.
Published: (2008)
by: Zh. A. Misharina, et al.
Published: (2008)
Inducible dominant negative ErbB2 rat spermatogonial line for generation of transgenic rat model and dissecting ERBB2 tyrosine kinase mediated pathways
by: Syvyk, A.E., et al.
Published: (2023)
by: Syvyk, A.E., et al.
Published: (2023)
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
by: I. O. Sviezhentseva, et al.
Published: (2015)
by: I. O. Sviezhentseva, et al.
Published: (2015)
Effect of protein kinase CK2 inhibitors on its catalytic subunits SK2α and SK2α´
by: O. V. Ostrynska, et al.
Published: (2014)
by: O. V. Ostrynska, et al.
Published: (2014)
Similar Items
-
Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
by: Zhaleiko, I.O., et al.
Published: (2014) -
Tyrosine kinase inhibitors in treatment of fibrous histiocytoma
by: Maur, D., et al.
Published: (2009) -
Influence of tyrosine proteine kinases inhibitor, genestein, on Agrobacterium – mediated plant transformation
by: V. Fedorchuk, et al.
Published: (2015) -
Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
by: Ya. A. Sheremet, et al.
Published: (2012) -
Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
by: Sheremet, Ya.A., et al.
Published: (2012)